News|Articles|April 1, 2025

Hepatology Month in Review: March 2025

Name: Reflecting on Resmetirom’s Historic FDA Approval for MASH
Uploaded: 2025-04-01T10:00:00Z
Duration: 9 min 49 s
Description: Reflecting on Resmetirom’s Historic FDA Approval for MASH

Author(s)Abigail Brooks, MA

Fact checked by: Tim Smith

The month in review spotlights coverage of the anniversary of resmetirom’s FDA approval and research in autoimmune hepatitis, HBV vaccination, and MASLD.

March brought key developments in the field of hepatology, ranging from advances in drug development to new research into notable liver disease risk factors.